GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Researchers Demonstrate Coherent Quantum Transport in MoS₂ Integrated into Field-Effect Transistor Arrays

by GOAI
Share To

Researchers have successfully demonstrated coherent quantum transport in monolayer semiconductors by integrating molybdenum disulfide (MoS₂) into field-effect transistor (FET) arrays. The study highlights advanced electronic properties of these materials, which may contribute to the development of more efficient semiconductor technologies. The research employed vicinal van der Waals epitaxy, a technique enabling the seamless transfer of single-crystalline MoS₂ onto FET arrays.

The use of vicinal van der Waals epitaxy allowed researchers to achieve precise alignment and integration of the monolayer material, ensuring high-quality crystalline structures within the transistors. This approach facilitated coherent quantum transport, a phenomenon where electrons move through the material without scattering, enhancing conductivity and performance. The findings suggest that monolayer semiconductors like MoS₂ could play a significant role in advancing next-generation electronic devices due to their unique properties and compatibility with existing semiconductor fabrication methods.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top